A critical advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor protector protein is frequently disabled in various types of malignancies, resulting https://socialskates.com/story23429171/vhh-fragments-restore-tumor-suppressor-p53-the-potential-approach-for-tumor-therapy